The role of mitochondrial dynamics in cardiovascular diseases
- PMID: 32294237
- DOI: 10.1111/bph.15068
The role of mitochondrial dynamics in cardiovascular diseases
Abstract
The process of mitochondrial dynamics is emerging as a core player in cardiovascular homeostasis. This process refers to the co-ordinated cycles of biogenesis, fusion, fission and degradation to which mitochondria constantly undergo to maintain their integrity, distribution and size. These mechanisms represent an early response to mitochondrial stress, confining organelle portions that are irreversibly damaged and preserving mitochondrial function. Accumulating evidence demonstrates that impairment in mitochondrial dynamics leads to myocardial damage and cardiac disease progression in a variety of disease models, including pressure overload, ischaemia/reperfusion and metabolic disturbance. These findings suggest that modulation of mitochondrial dynamics may be considered as a valid therapeutic strategy in cardiovascular diseases. In this review, we discuss the current evidence about the role of mitochondrial dynamics in cardiac pathophysiology, with a particular focus on the mechanisms underlying the development of cardiac hypertrophy and heart failure, metabolic and genetic cardiomyopathies, ischaemia/reperfusion injury, atherosclerosis and ischaemic stroke. LINKED ARTICLES: This article is part of a themed issue on Cellular metabolism and diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.10/issuetoc.
© 2020 The British Pharmacological Society.
Similar articles
-
Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.Br J Pharmacol. 2020 Dec;177(23):5336-5356. doi: 10.1111/bph.15021. Epub 2020 Mar 21. Br J Pharmacol. 2020. PMID: 32059259 Free PMC article. Review.
-
Ageing, sex, and cardioprotection.Br J Pharmacol. 2020 Dec;177(23):5270-5286. doi: 10.1111/bph.14951. Epub 2020 Feb 3. Br J Pharmacol. 2020. PMID: 31863453 Free PMC article. Review.
-
Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials.Br J Pharmacol. 2019 Nov;176(22):4302-4318. doi: 10.1111/bph.14431. Epub 2018 Aug 2. Br J Pharmacol. 2019. PMID: 29968316 Free PMC article. Review.
-
Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.Br J Pharmacol. 2017 Jun;174(12):1555-1569. doi: 10.1111/bph.13704. Epub 2017 Feb 8. Br J Pharmacol. 2017. PMID: 28060997 Free PMC article. Review.
-
Mitochondrial dynamics, mitophagy and cardiovascular disease.J Physiol. 2016 Feb 1;594(3):509-25. doi: 10.1113/JP271301. Epub 2016 Jan 15. J Physiol. 2016. PMID: 26537557 Free PMC article. Review.
Cited by
-
Roles of O-GlcNAcylation in Mitochondrial Homeostasis and Cardiovascular Diseases.Antioxidants (Basel). 2024 May 6;13(5):571. doi: 10.3390/antiox13050571. Antioxidants (Basel). 2024. PMID: 38790676 Free PMC article. Review.
-
Deletion of Sigmar1 leads to increased arterial stiffness and altered mitochondrial respiration resulting in vascular dysfunction.Front Physiol. 2024 Apr 29;15:1386296. doi: 10.3389/fphys.2024.1386296. eCollection 2024. Front Physiol. 2024. PMID: 38742156 Free PMC article.
-
Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease.Cells. 2024 Feb 17;13(4):353. doi: 10.3390/cells13040353. Cells. 2024. PMID: 38391966 Free PMC article. Review.
-
Mzb1 Attenuates Atherosclerotic Plaque Vulnerability in ApoE-/- Mice by Alleviating Apoptosis and Modulating Mitochondrial Function.J Cardiovasc Transl Res. 2024 Jan 31. doi: 10.1007/s12265-024-10483-0. Online ahead of print. J Cardiovasc Transl Res. 2024. PMID: 38294627
-
Prenatal hormone stress triggers embryonic cardiac hypertrophy outcome by ubiquitin-dependent degradation of mitochondrial mitofusin 2.iScience. 2023 Dec 8;27(1):108690. doi: 10.1016/j.isci.2023.108690. eCollection 2024 Jan 19. iScience. 2023. PMID: 38235340 Free PMC article.
References
REFERENCES
-
- Alavi, M. V., Bette, S., Schimpf, S., Schuettauf, F., Schraermeyer, U., Wehrl, H. F., … Knipper, M. (2007). A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain, 130, 1029-1042.
-
- Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., … Southan, C. (2019). The Concise Guide to pharmacology 2019/20: Introduction and other protein targets. British Journal of Pharmacology, 176(Suppl 1), S1-S20.
-
- Anand, R., Wai, T., Baker, M. J., Kladt, N., Schauss, A. C., Rugarli, E., & Langer, T. (2014). The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. The Journal of Cell Biology, 204, 919-929. https://doi.org/10.1083/jcb.201308006
-
- Ashrafian, H., Docherty, L., Leo, V., Towlson, C., Neilan, M., Steeples, V., … Dear, T. N. (2010). A mutation in the mitochondrial fission gene Dnm1l leads to cardiomyopathy. PLoS Genetics, 6, e1001000. https://doi.org/10.1371/journal.pgen.1001000
-
- Barsoum, M. J., Yuan, H., Gerencser, A. A., Liot, G., Kushnareva, Y., Graber, S., … White, A. D. (2006). Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. The EMBO Journal, 25, 3900-3911. https://doi.org/10.1038/sj.emboj.7601253
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical